Glezer Stanislav 4
4 · Inogen Inc · Filed May 3, 2024
Insider Transaction Report
Form 4
Inogen IncINGN
Glezer Stanislav
EVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-05-01$7.05/sh−16,695$117,700→ 32,049 total - Exercise/Conversion
Restricted Stock Unit
2024-05-01−32,638→ 0 total→ Common Stock (32,638 underlying) - Exercise/Conversion
Common Stock
2024-05-01+32,638→ 48,744 total
Footnotes (3)
- [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on May 1, 2024.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F3]Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024